Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
Already a member? Log in here
Emerging Tests-dtet
Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
Methylation Patterns Are New Target for ctDNA Analysis
...
Already a member? Log in here
Disposable, Electrochemical Sensor IDs Wound Infections in Seconds
...
Already a member? Log in here
Inflammatory Markers May Diagnose Back Conditions
...
Already a member? Log in here
NGS-Based Test for CF Promises Faster, Cheaper, More Thorough Analysis
...
Already a member? Log in here
More Than 1/4 of FDA’s 2015 Drug Approvals for Targeted Therapies
From – Diagnostic Testing & Emerging Technologies
More than 28 percent of the novel new drugs approved by U.S. Food and Drug Administration (FDA) in 2015 were…
Already a member? Log in here
New Molecular Test for Cystic Fibrosis Promises Faster, Better, Cheaper Analysis
From – Diagnostic Testing & Emerging Technologies
The future of cystic fibrosis (CF) diagnosis is in sight. Testing for the genetic disease helped to fuel the first wave of clinical molecular diagnostics, and now an assay developed by…
Already a member? Log in here
Paper-Based Test May Increase Male Fertility Self-Testing
...
Already a member? Log in here
Cost Effectiveness of Nail Fungus Confirmatory Test Treatment-Specific
...
Already a member? Log in here
Rise in Lyme Cases Drives Interest in New Tests
...
Already a member? Log in here